Search results

-
Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone

-
Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables

-
Fluid loss does not explain coagulation activation during air travel

-
A guide to murine coagulation factor structure, function, assays, and genetic alterations

-
Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables

-
A model for the harmonisation of test results of different quantitative D-dimer methods

-
Fibrinolytic efficacy of amediplase, tenecteplase and scu-PA in different external plasma clot lysis models

-
The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: A randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women

-
Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol

-
Clot penetration and fibrin binding of amediplase, a chimeric plasminogen activator (K2tu-PA)

-
Variable hypocoagulant effect of fish oil intake in humans: Modulation of fibrinogen level and thrombin generation

-
Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients

-
13-Week oral toxicity study with isomaltulose (Palatinose®) in rats

-
The effect of alcohol ingestion on the exercise-induced changes in fibrin and fibrinogen degradation products in man

-
Acceleration of fibrinolysis by high-frequency ultrasound: The contribution of acoustic streaming and temperature rise

-
Importance of levonorgestrel dose in oral contraceptives for effects on coagulation

-
13-week oral toxicity study with stanol esters in rats

-
Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study

-
Hypocoagulant and lipid-lowering effects of dietary n-3 polyunsaturated fatty acids with unchanged platelet activation in rats

-
Effect of oral contraceptives on haemostasis variables